about
Structural basis of Vps33A recruitment to the human HOPS complex by Vps16Molecular model of a type III secretion system needle: Implications for host-cell sensingStructural basis for the recognition of ldb1 by the N-terminal LIM domains of LMO2 and LMO4Structures of the Shigella flexneri Type 3 Secretion System Protein MxiC Reveal Conformational Variability Amongst HomologuesCrystal structure of Spa40, the specificity switch for theShigella flexneritype III secretion systemNeisseria meningitidis recruits factor H using protein mimicry of host carbohydratesStructural and Functional Studies on the N-terminal Domain of the Shigella Type III Secretion Protein MxiGInsights into Krabbe disease from structures of galactocerebrosidaseArchitecture of the major component of the type III secretion system export apparatusStructural snapshots illustrate the catalytic cycle of β-galactocerebrosidase, the defective enzyme in Krabbe disease.New therapeutic approaches for Krabbe disease: The potential of pharmacological chaperones1H, 15N and 13C assignments of FLIN4, an intramolecular LMO4:ldb1 complexThe binding of TAPBPR and Tapasin to MHC class I is mutually exclusive.TAPBPR alters MHC class I peptide presentation by functioning as a peptide exchange catalystTAPBPR bridges UDP-glucose:glycoprotein glucosyltransferase 1 onto MHC class I to provide quality control in the antigen presentation pathway.Azasugar inhibitors as pharmacological chaperones for Krabbe diseaseExpression, purification, crystallization and preliminary crystallographic analysis of MxiH, a subunit of the Shigella flexneri type III secretion system needle.Expression, limited proteolysis and preliminary crystallographic analysis of IpaD, a component of the Shigella flexneri type III secretion system.Expression, purification, crystallization and preliminary crystallographic analysis of BipD, a component of the Burkholderia pseudomallei type III secretion systemSelf-chaperoning of the type III secretion system needle tip proteins IpaD and BipD.The type III needle and the damage done.What's the point of the type III secretion system needle?Competition between LIM-binding domains.Timing is everything: the regulation of type III secretion.Molecular Mechanisms of Disease Pathogenesis Differ in Krabbe Disease Variants.The Shigella Virulence Factor IcsA Relieves N-WASP Autoinhibition by Displacing the Verprolin Homology/Cofilin/Acidic (VCA) DomainTandem LIM domains provide synergistic binding in the LMO4:Ldb1 complex.Characterisation of Shigella Spa33 and Thermotoga FliM/N reveals a new model for C-ring assembly in T3SS.Structure of human saposin A at lysosomal pH.SepL resembles an aberrant effector in binding to a class 1 type III secretion chaperone and carrying an N-terminal secretion signalCrystallization of FLINC4, an intramolecular LMO4-ldb1 complex.The mechanism of glycosphingolipid degradation revealed by a GALC-SapA complex structure.TAPBPR mediates peptide dissociation from MHC class I using a leucine leverThe homophilic receptor PTPRK selectively dephosphorylates multiple junctional regulators to promote cell-cell adhesionDesign, production and characterization of FLIN2 and FLIN4: the engineering of intramolecular ldb1:LMO complexesThe lipid transfer protein Saposin B does not directly bind CD1d for lipid antigen loadingAntagonism of PP2A is an independent and conserved function of HIV-1 Vif and causes cell cycle arrestMolecular models should not be published without the corresponding atomic coordinates
P50
Q24313126-5B5F816C-8B1F-4621-99E8-931FED4F5593Q24670035-5E031471-CEDB-47F2-B038-B11A0B86B4D5Q24676096-E1A48E3C-7319-4400-A4E2-90D1E195F082Q27649946-091F24EF-13C0-42D3-8A6B-632EADED0F8BQ27650631-0E21A038-BCC4-4F7B-BF81-719D88472E83Q27653843-FD5E64AD-F40C-4876-8D87-D041FEF00B7FQ27670706-601D1DA7-3AC5-48E0-99D9-13D170514FF0Q27672430-05EBE98C-DD71-4E42-9CBC-9DE50F7B5350Q27675415-70150A0C-188D-4E9E-BBA9-A4E7220BA708Q27680741-F23D97FD-0C9C-4DE1-ABD8-32CF47DBF56AQ28068142-A4228F7F-7540-4696-9DD9-15452119E452Q28216647-92CB10F1-4C3A-4CD7-AAB4-5C7762747994Q30668568-E46C8375-1039-4C7D-87B5-000E6B675CC0Q30668579-AD50A305-E958-4B33-A938-47402E897284Q33719590-01241421-8862-4FEF-B62B-0E8C74DA8DFFQ35652295-5D4FFDAB-222B-42FB-BA9C-22E7B227D4B7Q35846725-AB88BE44-E189-47F5-B2A6-47E20243F5A7Q35846730-1BEAD8E0-4BF8-4DED-940C-3DEDB27222BCQ35846733-2FB7C10D-FEEF-4130-8C19-2780D2052D51Q35846739-11C23332-5FD9-470B-B402-A3C358E02E75Q36303183-11A4E9CE-7E0A-47D3-9B7D-FFF6103677F3Q36638746-7C1980E7-00FF-4D9C-9F2E-22FE61E4A295Q37330460-C4C1F795-6F2A-4234-8345-F9D37EDD8AE2Q37665331-DB499B64-DD20-4B85-8E28-079D5FB43E31Q38874171-FCC68C72-D06E-4C8B-AC3E-8166880A8E68Q39157867-3BDB8201-9CB2-40FD-A260-1FA99DE86C8AQ40018790-4230152B-D3C8-493D-A904-87BED0D0A4F4Q40194202-692C8AA0-FCBB-40BA-A1CE-B993DDD2D472Q40767844-20D34CBD-ED08-4574-BF1E-56EB61CD56F1Q42375349-1F04B86F-E098-4ED3-B897-08300869CD5AQ47742274-BC6B8368-607E-401A-9CD9-22ABC4F85D36Q48263330-AFC31E1D-84A7-4451-8458-7CAC8485981CQ60931379-9AC032F0-0BCF-4BF1-988D-5D941955F54FQ64101666-9F0D6523-D659-4F79-85E5-0BD4F024CB1BQ74425233-AB723862-5962-4E70-8715-D570DC75B399Q91017318-A009BBE1-C0B4-40D5-8778-1DDCC1CC311FQ91940625-A2F5D9B5-24D7-485D-9FBC-05D075BA36E6Q92524443-29B0A74C-A0D0-423A-B857-59F4DE9B3AC1
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Janet E Deane
@ast
Janet E Deane
@en
Janet E Deane
@es
Janet E Deane
@nl
type
label
Janet E Deane
@ast
Janet E Deane
@en
Janet E Deane
@es
Janet E Deane
@nl
prefLabel
Janet E Deane
@ast
Janet E Deane
@en
Janet E Deane
@es
Janet E Deane
@nl
P106
P21
P31
P496
0000-0002-4863-0330